Loading...
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Rationale: Chronic azithromycin is commonly used in cystic fibrosis based on short controlled clinical trials showing reductions in pulmonary exacerbations and improved FEV(1). Long-term effects are unknown. Objectives: Examine pulmonary outcomes among chronic azithromycin users compared with matche...
Na minha lista:
| Udgivet i: | Am J Respir Crit Care Med |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Thoracic Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049934/ https://ncbi.nlm.nih.gov/pubmed/31661302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1206OC |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|